161.00
161.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
TAMILONG 20 Tablet contains Tamoxifen Citrate, an estrogen receptor modulator primarily used in the treatment and prevention of breast cancer. It is commonly prescribed for hormone receptor-positive breast cancer in both premenopausal and postmenopausal women.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
TAMILONG 20 Tablet is a potent anti-estrogenic medication formulated with Tamoxifen Citrate, widely used in the management of hormone receptor-positive breast cancer. It is categorized as a selective estrogen receptor modulator (SERM), which means it can block estrogen's effects in breast tissue while potentially maintaining estrogenic activity in other tissues such as the bones and uterus. This dual mechanism makes TAMILONG 20 both effective and versatile in clinical oncology.
Tamoxifen, the active ingredient in TAMILONG 20 Tablet, works by binding to estrogen receptors on cancer cells, thereby blocking the hormone estrogen from attaching. Since certain types of breast cancers rely on estrogen for growth, this blockade results in the slowing or complete stoppage of tumor proliferation. As such, the drug is most effective in estrogen receptor-positive breast cancers and is used across various stages, including early-stage disease, metastatic conditions, and for prophylactic purposes in high-risk individuals.
TAMILONG 20 is also used in the prevention of breast cancer in women who are at a higher risk due to family history, age, or genetic predispositions such as BRCA mutations. It has shown effectiveness in reducing the incidence of contralateral breast cancer and is a cornerstone of adjuvant therapy after surgery, chemotherapy, or radiation.
This tablet is typically administered once or twice daily depending on the clinical requirement, and treatment duration may vary from five to ten years. It is a well-established standard in hormonal therapy and is included in major global oncology treatment guidelines. Apart from breast cancer, TAMILONG 20 may also be prescribed in certain cases of infertility, gynecomastia, and ovulation induction under strict medical supervision.
Manufactured by Bluepill Express, TAMILONG 20 is developed in accordance with stringent international pharmaceutical manufacturing norms including WHO-GMP, ISO, and DCGI guidelines. Each tablet undergoes thorough quality control checks, including assay validation, dissolution testing, and stability profiling to ensure efficacy, safety, and consistency. It is available in secure blister packaging that maintains product integrity over its shelf life.
Bluepill Express offers TAMILONG 20 Tablet for third-party manufacturing and export with customizable branding, documentation, and support services. Clients can opt for various packaging sizes, regional label printing, and supply formats tailored to market-specific regulatory demands. Complete technical dossiers such as Certificate of Analysis (COA), Batch Manufacturing Records (BMR), and MSDS are available to support product registration globally.